CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Trends Analyst Outlook Journalist POV

28 hedge funds and large institutions have $2.25M invested in CASI Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$102K
2
+$58K
3
+$16K
4
MC
Moors & Cabot
Massachusetts
+$14.8K
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.68K

Top Sellers

1
-$14K
2
-$13K
3
-$2.76K
4
BFA
BlackRock Fund Advisors
California
-$2.28K
5
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$595K
2
$519K
3
$406K
4
$239K
5
$145K
6
$83K
7
$58K
8
$46K
9
$38K
10
$18K
11
$18K
12
$18K
13
$17K
14
$16K
15
$11K
16
$8K
17
$5K
18
$3K
19
$2K
20
$41
21
–
22
–
23
–